Patterns of Relapse and Associated Cost Burden in Schizophrenia Patients Receiving Atypical Antipsychotics

被引：0
|
作者：
Lafeuille, Marie-Helene [1 ]
Gravel, Jonathan [1 ]
Lefebvre, Patrick [1 ]
Fasteneau, John [2 ]
Muser, Erik [2 ]
Doshi, Dilesh [2 ]
Dug, Mei Sheng [3 ]
机构：
[1] Grp Anal Ltee, Montreal, PQ, Canada
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Anal Grp Inc, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
952
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [41] Positive encenicline exposure-response relationships for cognition and clinical function in schizophrenia patients receiving atypical antipsychotics
    Loewen, G.
    Kuan, H.
    Dgetluck, N.
    Hilt, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S471 - S472
  • [42] Utilization and cost of atypical antipsychotics in Medicaid patients with depression
    Markowitz, J
    Meletiche, DM
    VALUE IN HEALTH, 2003, 6 (03) : 359 - 359
  • [43] Comparison of Re-Hospitalization and Emergency Room Visit Patterns Among Patients with Schizophrenia Receiving Paliperidone Palmitate or Oral Atypical Antipsychotics in an Inpatient Setting
    Lafeuille, Marie-Helene
    Grittner, Amanda
    Muser, Erik
    Fastenau, John
    Duh, Mei Sheng
    Lefebvre, Patrick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 253 - 253
  • [44] Treatment Persistence Associated with Typical versus Atypical Antipsychotics among Out-patients with Schizophrenia
    Adeosun, Increase Ibukun
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 10 (04):
  • [45] Quality of life and tolerability in patients with schizophrenia taking atypical antipsychotics
    Edwards, S. J.
    Hadlow, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S466 - S466
  • [46] Adverse Drug Reactions Affiliated with Atypical Antipsychotics in Patients with Schizophrenia
    Oommen, Shweta
    Elango, P.
    Alwar, M. C.
    Solomon, Susan
    JOURNAL OF YOUNG PHARMACISTS, 2019, 11 (03) : 315 - 319
  • [47] Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics
    Watanabe, A
    Shibata, I
    Kato, T
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (03) : 268 - 273
  • [48] A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
    Marilena Gilca
    Gabriela Piriu
    Laura Gaman
    Corina Delia
    Liviu Iosif
    Valeriu Atanasiu
    Irina Stoian
    Psychopharmacology, 2014, 231 : 4703 - 4710
  • [49] Quality of life and tolerability in patients with schizophrenia taking atypical antipsychotics
    Fleming, K.
    Potkin, S. G.
    Binneman, B.
    Keller, D.
    Alphs, L.
    Panagides, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S466 - S467
  • [50] Efficacy of the new formulations of atypical antipsychotics in patients with chronic schizophrenia
    Vasile, D.
    Vasiliu, O.
    Vasiliu, D.
    Vasile, F.
    EUROPEAN PSYCHIATRY, 2020, 63 : S550 - S551
12345